Psoriasis is an autoimmune disease that affects patients’ quality of life and can be costly. Various treatments are available including topical and systemic agents. Please join us for Psoriasis from a Medical Perspective with guest faculty, John Strasswimmer, M.D.

Internal Medicine Physicians, Dermatologists, Physician Assistants, Residents, Advanced Practice Registered Nurses, Pharmacists and all other interested healthcare providers.


  • Explain psoriasis, its links with internal media and current treatment approaches 
  • Describe necessary work up of a patient with suspected new onset psoriasis
  • Discuss associations with chronic liver and vascular diseases 
  • Examine the role of topical agents including proper emollient use
  • Appraise current systemic approaches to treatment of psoriasis including antimetabolites, systemic immunosuppressants, interferon- and interleukin antagonists. 


John M. Strassmimmer, M.D., Ph.D.
Founding Director, Melanoma & Cutaneous Oncology Program 
Lynn Cancer Institute, 
Boca Raton Regional Hospital
Baptist Health South Florida
Professor, Affiliate, of Medicine (Dermatology)
Professor, Affiliate, of Biochemistry
Florida Atlantic University
Boca Raton, Florida

John M. Strasswimmer, M.D., indicated that he is a consultant for Regeneron and Castle Bioscience. He is also a a speaker for Regeneron, Sanofi, and Genentech.  Dr. Strasswimmer also indicated that he is a researcher for Regeneron, Biofrontera, and Almirall.  All of the relevant financial relationships listed for these individuals have been mitigated.

John Rubin, M.D., director for this educational event, owns stock in AstraZeneca and Bristol Myers Squibb. He has indicated that the presentation or discussion will not include off-label or unapproved product usage. All of the relevant financial relationships listed for this individual have been mitigated.  

Kenneth Rosenthal, M.D., FACG, moderator for this educational event, indicated that he is on the Speaker’s Bureau for AbbVie, Inc. All of the relevant financial relationships listed for this individual has been mitigated. 

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
Disclosure Policy and Disclaimer


Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

This activity has been approved for 1 credit hour, CE Broker Course #20-855339, by the Florida Boards of Medicine, Podiatry, Dentistry, Osteopathic Medicine and Physician Assistants.  

This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Pharmacy Techs, Athletic Trainers. Baptist Health South Florida CE Broker Provider #50-182.

Session date: 
06/28/2022 - 7:30am to 8:30am EDT
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Florida Board of Athletic Training
  • 1.00 General certificate of attendance
  • 1.00 Florida Board of Dentistry
  • 1.00 Florida Board of Dietitians
  • 1.00 Nurse Practitioners
  • 1.00 Florida Board of Nursing
  • 1.00 Florida Board of Pharmacy

Please login or register for a Baptist Health CME account to take this course.